Objective: Complete resection is the therapy of choice in non-small-cell lung cancer (NSCLC). There is no agreement on the type of resection, especially when interlobar N1 disease is present. The present study explored the effect of the type of resection on survival in the presence of N1 disease. Method: Medical records of 195 patients with NSCLC who underwent resection between 1998 and 2006 and whose histopathological examination showed N1 disease were reviewed retrospectively. This study included 162 patients with T status of T1, T2 or T3, who had complete resection (excluding superior sulcus tumours). The patients were divided into three groups, namely hilar N1 (n = 15, 9.3%), interlobar N1 (N1-i) (n = 54, 33.3%) and lobar N1 (n = 93, 57.4%). Frequency comparisons were carried out by chi-square test. Survival rates were calculated by the Kaplan-Meier method and compared by log-rank test after patients who had operative mortality (n = 10, 6.2%) were excluded. Results: Seventyseven patients (47.5%) had lobectomy, 14 (8.6%) had bilobectomy (BL) and 71 (43.8%) had pneumonectomy (PN). Twenty-one of these patients (13.0%) had sleeve lobectomy and 19 had (11.7%) additional interventions (such as resection of the diaphragm or thoracic wall). Among all N1 patients, 5-year survival rate was 56.9% in patients who had BL or PN and 46.8% in patients who had lobectomy, a difference not statistically significant ( p = 0.09). Similarly, there was no significant difference between patients who had sleeve resection and PN ( p = 0.58). The type of resection was not found related to survival in the presence of interlobar ( p = 0.75). Similarly, type of resection was not significantly associated with survival in patients with hilar N1 ( p = 0.86). Conclusion: Those who had PN or BL had a higher survival rate, which was statistically insignificant. Further studies are required to determine whether or not the type of resection should be changed as a result of N1 only. #
Introduction
Metastasis to the station 10 and lymph nodes distal to it is defined as N1 in the TNM (tumour, node, metastasis) staging of lung cancers [1] . In this staging system, the presence of N1 alters the stage of the disease, except cancers in stage T4.
The pN1 patients who had had resection had 27-67% 5-year survival rates [2] . Several studies have been conducted regarding the factors affecting survival of pN1 lung cancer patients. The prognosis of hilar or interlobar N1 cases is worse than peripheral N1 cases [3, 4] . The extent of lymph node involvement in patients with non-small-cell lung cancer (NSCLC) is the most important prognostic factor and influences therapeutic strategies [5] . There are limited data on the impact of the type of resection on survival in N1 patients. In the presence of N1, beneficial effect of pneumonectomy on survival would be expected [6, 7] .
Presence of especially interlobar N1 may be critical in the process of choosing the type of resection. The present study investigated the effects of the type of resection on survival in the presence of N1 disease.
Methods
Medical records of 195 patients who underwent resection for NSCLC in our hospital between January 1998 and December 2006 and had pathologically confirmed N1 disease were reviewed retrospectively. The patients had appropriate pulmonary resection and systematic mediastinal lymph node dissection. All patients who had neo-adjuvant chemo-and/or radiotherapy have been excluded from the study. Resection was defined as complete by a pathological demonstration of negative tissue margins and by the judgement of the operating surgeon who had removed all detectable disease and performed a mediastinal lymph node dissection [8] . This www.elsevier.com/locate/ejcts European Journal of Cardio-thoracic Surgery 37 (2010) 446-450 study group comprised 162 patients in whom complete resection could be achieved and whose histopathological examination showed stage T1, T2 or T3 (with the exception of patients with superior sulcus tumour).
The mean age of the patients was 56.9 years (range: 39-78), with six females (3.7%) and 156 males (96.3%). For preoperative staging, cranial tomography or magnetic resonance imaging (MRI) were also carried out in all of cases. Moreover, bone scan and abdominal ultrasonography or positron emission tomography (PET) were performed in all cases. A total of 151 patients (93.2%) had preoperative mediastinoscopy for mediastinal staging. Mediastinoscopy was not found to be necessary in cases with negative mediastinum in either tomography or positron emission tomography. Seventy-seven patients (47.5%) had lobectomy, 14 (8.6%) had bilobectomy (BL) and 71 (43.8%) had pneumonectomy (PN). Of the patients who had undergone lobectomy, 21 (13.0%) underwent sleeve lobectomy. Nineteen patients (11.7%) had extended resection (resection of the diaphragm and thoracic wall); of these, 11 had undergone lobectomy, whereas two and six patients had bilobectomy and pneumonectomy, respectively. Pneumonectomy was performed for interlobar fissure invasion in 46 (64.8%), for invasion of the central structures (invasion of the proximal pulmonary artery, extensive bronchial invasion not suitable for sleeve resection) in 21 (29.6%) and for fixed interlobar N1 (N1-i) in only four (5.6%) patients.
Operative mortality was recorded as any hospital mortality and deaths within 30 days of discharge when patients are discharged before 30 days. Histopathological examination revealed that 15 cases (9.3%) were pT1, 78 (48.1%) were pT2 and 69 (42.6%) were pT3. N1 state was investigated in three groups. Hilar N1, interlobar N1 (without hilar N1) and lobar N1 (metastases to lymph nodes numbers 12, 13 and 14) were identified in 15 (9.3%), 54 (33.3%) and 93 (57.4%) patients, respectively. Certain characteristics of patients are presented in Table 1 .
Four-cycle cisplatin-based adjuvant chemotherapy was given to patients with pN2 disease. The patients with lobar N1 who underwent complete resection did not have oncological therapy following surgery. The patients with hilar or interlobar N1 had no uniform protocol for postoperative adjuvant therapy. Only a few patients had received adjuvant therapy. All patients were followed up at 6-month intervals and examined for local recurrence or metastasis. A chest computerised tomography was done every 6 months until the postoperative year 5. Three patients were lost to follow-up. Mean follow-up duration was 33.2 AE 22.5 months (range: 3-106 months). Survival was calculated as the duration between the date of the operation and the date of last follow-up or demise.
Since it is a retrospective study without disclosure of patients' identities, institutional review board approval was waived.
Statistics
Data was analysed statistically. Chi-square test, Fisher's exact test and one-way analysis of variance (ANOVA) were used to compare means and frequencies. Survival analyses were carried out for prognostic factors (e.g., cell type, T status, tumour size and type of resection). Survival was calculated by the Kaplan-Meier survival analysis, taking the day of resection as day 0. The effect of each variable on survival was examined by log-rank test. Cox analysis was used for multivariate survival analysis. A p-value of at least 0.05 was considered significant.
Results
There were no significant differences between patients in resection subtypes with regard to age ( p = 0.34), sex ( p = 0.39), tumour size ( p = 0.43) and operative mortality ( p = 0.87). Squamous cell type was found more frequently in patients who underwent lobectomy compared with patients who had undergone BL or PN ( p = 0.01) ( Table 1) . Operative mortality was observed in five cases of lobectomy (6.6%), four The mean number of dissected mediastinal lymph nodes was 8.3 AE 4.84 (standard deviation), median number was 7, ranging from 3 to 30. The mean number of dissected and/or evaluated N1 lymph nodes was 7 AE 6.1 (SD; ranging from 2 to 37). The mean number of positive N1 nodes was 2.2 AE 2.1 (SD; ranging from 1 to 14). The mean number of positive N1 station was 1.3 AE 0.7 (ranging from 1 to 4).
Compared with other N1 groups, frequency of patients who had BL or PN in the interlobar N1 (N1-i) group was higher than those who had lobectomy ( p < 0.001). Among patients with N1-i, 13 (24.1%) had lobectomy, seven (13.0%) had bilobectomy and 34 (63.0%) had pneumonectomy. There was no statistically significant relation between resection type (pneumonectomy and bilobectomy vs lobectomy) and T status ( p = 0.26) ( Table 1) . However, when the distribution of N1 groups with regard to T status was considered, we noted that N1-i was more frequent among pT3 cases ( p = 0.006). A pT1 or pT2 was present in 59.3% (n = 9) of patients who had N1-i and underwent lobectomy (n = 13) while pT3 was present in 61% (n = 25) of the patients who underwent BL or PN (n = 41) ( p = 0.004). There were eight cases of lymph node metastasis that showed fixation to interlobar structures (14.8%) among patients with N1-i, three of which had interlobar fissure invasion and one had central tumour. All eight patients had pneumonectomy.
Survival analysis of all N1 patients showed no significant differences between histological subtypes ( p = 0.43) and tumours larger than 5 cm and smaller than 5 cm ( p = 0.20) ( Table 2 ). The 5-year survival rates of hilar N1, interlobar N1 and lobar N1 patients were 44.4%, 49.7% and 55.0%, Table 2 The impact of prognostic factors on survival in the presence of any N1.
respectively, but that difference was statistically insignificant ( p = 0.32). The 5-year survival among patients who had lobectomy was 46.8% while that among patients who had BL or PN was 56.9%, although the difference was not statistically significant ( p = 0.09). Hazard ratio was 0.59 (0.32-1.08) and the confidence interval was 95%, patients who had undergone lobectomy tended to live longer than the patients who underwent BL or PN (Fig. 1) . The 5-year survival rates in sleeve lobectomy and PN were 51.1% and 56.0%, respectively, and there was no statistically significant difference ( p = 0.58).
The T status ( p = 0.53), histological type ( p = 0.29) and tumour size ( p = 0.42) were not significantly related to survival in N1-i patients (Table 3) . Among these patients, with 57.0% as opposed to 47.0%, survival was better in lobectomy patients than those who had BL or PN, but the difference was not statistically significant ( p = 0.75). Hazard ratio was 1.23 (range: 0.35-4.27) and the confidence interval was 95%.
Similarly, the type of resection (lobectomy vs BL or PN) was not significantly associated with survival either in patients with hilar N1 ( p = 0.86) or lobar N1 ( p = 0.20).
Discussion
Stage is one of the most important prognostic factors in patients with NSCLC [1, 9, 10] . In 1997, lymph nodes were mapped and five stations were defined under N1 lymph nodes [11] . Some researchers argued that N1 was a more reliable prognostic factor, especially in T1 and T2 patients [3, 10] . There was no significant survival rate difference between T1 and T2 patients, while our study has the drawback of limited number of T1 patients. N1 status defines a heterogeneous group. Amongst all factors affecting survival in the presence of N1 disease, it has been reported that patients with hilar N1 had poorer survival than other N1 patients [4, 10] . Table 3 The impact of prognostic factors on survival in the presence of interlobar N1. There is a controversy over the type of resection to be performed in N1 patients, especially in the presence of interlobar N1. There are no randomised, prospective studies in this regard. A study by Tae Kim compared sleeve resection and pneumonectomy in N1 patients and found that comparable survival rates though local/regional recurrence was more frequent among patients who had sleeve resection, and the authors recommended sleeve resection for selected cases without a lymph node metastasis [12] . In contrast to that study, Watanabe et al. reported that they performed aggressive bronchial and pulmonary arterioplasties rather than pneumonectomy when N1 metastasis was mobile [13] .
The frequency of pneumonectomy among patients with N1 metastasis varies between 26% and 71% [4, 13] . In the present study, pneumonectomy was carried out in 43.8% of the patients. The frequency of pneumonectomy among patients with N1-i metastasis was 63.0% but only in four cases (5.5%) the indication for pneumonectomy was fixed N1-i.
In the present study, we did not find significant relations between the type of resection and survival among N1 patients. Type of resection was not significantly related to survival in the presence of N1-i. Similar to our study, Khan argued that beneficial effects of pneumonectomy could be expected in the presence of N1 but reported that this effect was not evident due to long-term cardiovascular complications secondary to pneumonectomy [6] . However, in our series, pneumonectomy or BL seemed to result in better survival compared with lobectomy, despite the fact that pneumonectomy caused more procedure-related complications and mortality, although the difference did not reach statistical significance. It can be plausible to speculate that PN or BL provided more extensive clearance of lymphatic sump [7] . That can be related to higher survival rates of our PN or BL patients. However, more studies are warranted in order to elucidate this subject.
In our patient series, adjuvant therapy protocols have not been same through the years. However, distribution of patients who underwent lobectomy, bilobectomy and pneumonectomy was found as well balanced when analysed (data not shown).
Survival rates of PN or BL patients were higher than survival rates of lobectomy patients, even though PN or BL patients had a higher hilar and interlobar N1 than lobectomy patients; however, the difference of survival rates was statistically insignificant. By randomised prospective studies, it is possible to establish whether the type of resection needs to be changed due to N1 alone.
